299 related articles for article (PubMed ID: 5451178)
41. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
[No Abstract] [Full Text] [Related]
42. A resected case of Mycobacterium szulgai pulmonary disease.
Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F
Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201
[TBL] [Abstract][Full Text] [Related]
43. [Depot drugs in the treatment of resistant forms of pulmonary tuberculosis. The experience of the Conjunto Sanatorial Octávio de Freitas (Recife)].
Rizzo A; Moura N; Magalhães M; Antunes G; Campelo C
Rev Bras Med; 1966 Dec; 23(12):850-2. PubMed ID: 5999012
[No Abstract] [Full Text] [Related]
44. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
Ivanova ES
Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
[No Abstract] [Full Text] [Related]
45. [Administration of reserve antitubercular drugs in a single daily dose].
Bek E; Bukalska Z; Zachara A
Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
[No Abstract] [Full Text] [Related]
46. Preclinical Development of Inhalable d-Cycloserine and Ethionamide To Overcome Pharmacokinetic Interaction and Enhance Efficacy against
Ranjan R; Srivastava A; Bharti R; Roy T; Verma S; Ray L; Misra A
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962335
[TBL] [Abstract][Full Text] [Related]
47. Multiple drugs in retreatment of chronic pulmonary tuberculosis. Results with capreomycin and ethambutol.
Organick AB; Wilson EM
Dis Chest; 1968 May; 53(5):560-70. PubMed ID: 5658968
[No Abstract] [Full Text] [Related]
48. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
Iaschenko BP
Probl Tuberk; 1967; 45(9):21-6. PubMed ID: 4303748
[No Abstract] [Full Text] [Related]
49. [Endocavernous treatment of caverns with atypical Mycobacteria].
Neef W
Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
[No Abstract] [Full Text] [Related]
50. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Suzuki T
Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
[No Abstract] [Full Text] [Related]
51. Management of drug failure cases.
Dingley HB
Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683
[No Abstract] [Full Text] [Related]
52. Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
Urbancik B
Antibiot Chemother; 1970; 16():281-6. PubMed ID: 5535614
[No Abstract] [Full Text] [Related]
53. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
[No Abstract] [Full Text] [Related]
54. Clinical and bacteriological results with Myambutol.
Goldman S; Brzaković N; Muzikravić T
Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
[No Abstract] [Full Text] [Related]
55. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
Virchow C; Flemming J
Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):40-6. PubMed ID: 5824389
[No Abstract] [Full Text] [Related]
56. Intermittent chemotherapy.
Tubercle; 1967 Mar; 48(1):58-61. PubMed ID: 4166513
[No Abstract] [Full Text] [Related]
57. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations].
Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA
Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920
[No Abstract] [Full Text] [Related]
58. [Bactericidal therapy in patients with tuberculosis].
Krasnov VA; Ursov IG
Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
[No Abstract] [Full Text] [Related]
59. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
KASS I
Tubercle; 1965 Jun; 46():151-65. PubMed ID: 14327963
[No Abstract] [Full Text] [Related]
60. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Pilipchuk NS
Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
